AUROBINDO PHARMA LTD’ (APL). APL is a growing Indian multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations. APL is 2nd Largest Generic Company as per Rx dispensed in the USA.APL is Amongst Top 10 Generic player in France, Germany, Portugal, UK, Italy, Czech Republic, Netherlands & Belgium.
AUROBINDO – WALK IN INTERVIEWS | 26-08-2023
We are having vacancies for Experienced Candidates in Production / Quality Control department at our Unit-VII (7), Jadcherla. interested candidates can directly attend the interview on 26th August 2023 (Saturday) at Jadcherla.
We are Hiring for Aurobindo Pharma Ltd, Unit -VII, Jadcherla:
Department: Production
- Position : Executive/Sr. Executive
- Area of exposure: Compression, Coating, Granulation & Capsule
- Qualification: B.Pharm / M.Pharm.
- Audit Exposure : USFDA, MHRA, EU etc..
- Dosage Form Exposure: Formulations (OSD)
- Experience: 3-6 years
Related Jobs: Aizant Drug Research Solutions – Walk-In Interviews for Freshers on 25th Aug’ 2023
Department: Quality Control
- Position : Executive/Sr. Executive
- Area of exposure: QC Exhibit & Microbiology
- Qualification: M.Sc (Micro)/B Pharma / M Pharma
- Audit Exposure: USFDA, MHRA, EU etc..
- Dosage Form Exposure: Formulations (OSD)
- Experience: 3-6 years
Walk-In Interview Details:
- Walk-In Date: 26-08-2023
- Interview & Job Location: Aurobindo Parma Ltd, Unit -VII, Plot No: 51 TSIIC – Pharma SEZ, Polepally Village, Jadcherla – Telangana -500090.
- Please Send the suitable CV to HRSEZ@aurobindo.com.
Related Jobs: Aurobindo Pharma – Walk-In Drive for QC / QA / ARD / FARD / Stability / Production / Packing on 24th Aug’ 2023
Related Jobs: Vital Therapeutics – Walk-In Interviews for Freshers & Experienced B.Pharm, M.Pharm, M.Sc, B.A, B.Com, MBA Candidates in QC / Accounts on 25th & 26th Aug’ 2023 @ Hyderabad
More Job Updates Join What’s App Group – Click Here
Join Telegram Group – Click Here
